A set of consensus neuropathological criteria for CTE were defined in 2016, which emphasize that tau-containing lesions in CTE differ from those of other tauopathies such as Alzheimer disease (AD), progressive supranuclear palsy (PSP) or corticobasal degeneration (CBD) [24]. Here, MAPT is linked to corticobasal degeneration disorder.